1-phenyl-2-palmitoylamino-3-morpholino-1-propanol and paclitaxel

1-phenyl-2-palmitoylamino-3-morpholino-1-propanol has been researched along with paclitaxel in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cabot, MC; Giuliano, AE; Gouazé, V; Liu, YY; Prickett, CS; Yu, JY1

Other Studies

1 other study(ies) available for 1-phenyl-2-palmitoylamino-3-morpholino-1-propanol and paclitaxel

ArticleYear
Glucosylceramide synthase blockade down-regulates P-glycoprotein and resensitizes multidrug-resistant breast cancer cells to anticancer drugs.
    Cancer research, 2005, May-01, Volume: 65, Issue:9

    Topics: Adenocarcinoma; ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Cell Line, Tumor; Down-Regulation; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Gangliosides; Glucosyltransferases; Humans; Morpholines; Oligonucleotides, Antisense; Paclitaxel; Sphingolipids; Transfection; Vinblastine

2005